Related Experiment Video

Updated: Aug 25, 2026

Investigating Alterations in Caecum Microbiota After Traumatic Brain Injury in Mice
04:29

Investigating Alterations in Caecum Microbiota After Traumatic Brain Injury in Mice

Published on: September 19, 2019

[Antibiotic treatment for traumatic brain injury patients without positive bacterial cultures]

Goro Nagashima1, Jun Sasaki, Masao Kuzume

  • 1Department of Neurosurgery, Fujigaoka Hospital, Showa University, 1-30 Fujigaoka, Aoba-ku, Yokohama-city, Kanagawa 227-8501, Japan. goro-n@po1.dti2.ne.jp

No Shinkei Geka. Neurological Surgery
|March 23, 2004
PubMed

Insights

Antibiotic selection for head-injured patients often lacks culture confirmation, leading to empiric use of cefalosporins and other agents. Preventing antibiotic resistance in traumatic brain injury requires careful selection and judicious use of antimicrobials.

Area of Science:

  • Infectious Diseases
  • Trauma Surgery
  • Pharmacology

Context:

  • Prophylactic antibiotic administration is common in trauma patients, especially those with head injuries, contaminated wounds, cerebrospinal fluid (CSF) leakage, or multiple injuries.
  • Empiric antibiotic therapy, often initiated with 1st or 2nd generation cefalosporins, is frequently used for traumatic patients, particularly when prolonged fever or inflammatory signs are present without confirmed infections.
  • Subsequent antibiotic selections are typically guided by clinical status rather than definitive culture results.

Purpose:

  • To analyze antibiotic selection patterns and the rationale behind these choices in 60 head-injured patients with a Glasgow Coma Scale (GCS) score under 12.
  • To evaluate the frequency of culture-confirmed infections influencing antibiotic choices in this patient cohort.
  • To identify strategies for preventing antibiotic resistance in traumatic brain injury (TBI) cases.

Summary:

  • Initial antibiotic treatments (cefazolin [CEZ], piperacillin [PIPC], or)}$.
  • Subsequent antibiotic selections, such as Cefoperazone/Sulbactam (CFSL) or Imipenem/Cilastatin (IPM/CS), were often made without positive culture results (85.7% for second-line, 50% for third-line).
  • The study highlights a trend of empiric antibiotic use, with limited reliance on microbiological data for treatment adjustments in head-injured patients.

Impact:

  • Emphasizes the critical need to prevent antibiotic resistance in traumatic brain injury patients through appropriate antibiotic selection.
  • Recommends strategies including judicious antibiotic use, exclusion of catheter-related infections, and the use of frequent cultures when infection sources are not apparent.
  • Informs clinical practice regarding antibiotic stewardship in the management of head-injured patients.

Related Concept Videos

Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...